| 序号 | HS编码 | 商品名称 | 英文名称 | 商品描述 | 退税率 | 计量单位 | 海关监管 | 状态 |
|---|---|---|---|---|---|---|---|---|
| 1 | 30033100.00 | 含有胰岛素的混合药品 | [Medicaments containing insulin(consisting of two or more constituents which have been mixed together, but not containing antibiotics, not put up in measured doses or in forms or packings for retail sale)] | 含有胰岛素的混合药品 | 13.00 % | 千克/无 | Q |
正常
|
| 2 | 30043110.10 | 已配剂量含重组人胰岛素的单方制剂 | [Single preparations, containing recombinant human insulin, put up in measured doses or packings for retail sale] | 已配剂量含重组人胰岛素的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 3 | 30043110.90 | 已配剂量含重组人胰岛素的其他药品 | [Other Medicaments , containing recombinant human insulin, without antibiotics, put up in measured doses or packings for retail sale] | 已配剂量含重组人胰岛素的其他药品 | 13.00 % | 千克/无 | Q |
正常
|
| 4 | 30043200.11 | 已配剂量含1-雄烯二醇或1-雄烯二酮的单方制剂 | [Single preparation containing andostenediol or androstenedione, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含1-雄烯二醇或1-雄烯二酮的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 5 | 30043200.12 | 已配剂量含甲酰勃龙的单方制剂 | [Single preparation containing formebolone, inclu- ding their derivatives and structural analog- ues, put up in measured doses, packings for retail sale] | 已配剂量含甲酰勃龙的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 6 | 30043200.13 | 已配剂量含雄甾-4-烯-3β, 17α-二醇（4-雄烯二醇（3β, 17α））的单方制剂 | [Single preparation containing androst-4-ene- 3β, 17α-diol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含雄甾-4-烯-3β, 17α-二醇（4-雄烯二醇（3β, 17α））的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 7 | 30043200.14 | 已配剂量含雄甾-5-烯-3β, 17α-二醇（5-雄烯二醇（3β, 17α））的单方制剂 | [Single preparation containing androst-5-ene- 3β,17α-diol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含雄甾-5-烯-3β, 17α-二醇（5-雄烯二醇（3β, 17α））的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 8 | 30043200.15 | 已配剂量含4-雄烯二醇或乙雌烯醇的单方制剂 | [Single preparation with 4-androstenediol and ethylestrenol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含4-雄烯二醇或乙雌烯醇的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 9 | 30043200.16 | 已配剂量含5-雄烯二酮的单方制剂 | [Single preparation containing androstene- dione isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含5-雄烯二酮的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 10 | 30043200.17 | 已配剂量含5α-雄烷-3α, 17β-二醇（雄烷二醇（3α, 17β））或5β-雄烷-3α, 17β-二醇（5β-雄烷二醇（3α, 17β））的单方制剂 | [Single preparation containing β-androstane- diol isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含5α-雄烷-3α, 17β-二醇（雄烷二醇（3α, 17β））或5β-雄烷-3α, 17β-二醇（5β-雄烷二醇（3α, 17β））的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 11 | 30043200.18 | 已配剂量5α-雄烷-3β, 17α-二醇（雄烷二醇（3β, 17α））的单方制剂 | [Single preparation containing androstanediol isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量5α-雄烷-3β, 17α-二醇（雄烷二醇（3β, 17α））的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 12 | 30043200.19 | 已配剂量含勃拉睾酮的单方制剂 | [Single preparation containing androstanediol isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含勃拉睾酮的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 13 | 30043200.21 | 已配剂量含勃地酮的单方制剂 | [Single preparation containing boldenone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含勃地酮的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
| 14 | 30043200.22 | 已配剂量含勃二酮的单方制剂 | [Single preparation containing 1, 4-androstadien-3, 17-diketone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含勃二酮的单方制剂 | 13.00 % | 千克/无 |
正常
|
|
| 15 | 30043200.23 | 已配剂量含卡芦睾酮或达那唑的单方制剂 | [Single preparation containing calusterone or danazol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale] | 已配剂量含卡芦睾酮或达那唑的单方制剂 | 13.00 % | 千克/无 | L |
正常
|
